Many antiviral treatments are set in motion for treating many issues today, and especially the COVID-19 infection. One such many options are Molnupiravir (โมลนูพิราเวียร์, term in Thai). It is a type of oral antiviral treatment that is employed for inhibiting the replication of a certain type of RNA virus. Hence, it is mainly used for treating the condition and symptoms of COVID-19.
SMPharmaceutical Industry is one of the many names of the pharmaceutical companies that have successfully launched supplements for treating Coronavirus infection. One such introduction from their company is Molnupiravir. It is a type of antiviral supplement that can take care of not only coronavirus infection, but also secondary infection from COVID-19 such as SARS, HIV, and so on.
Molnupiravir – what is it?
Molnupiravir is a type of prodrug and is derived from synthetic nucleosides. N4-hydroxycytidine is the synthetic nucleoside derivative that is the main source of this antiviral medication. The main work of this drug is to introduce the antiviral action in the body, whenever there is an error in copying during the process of RNA synthesis.
This drug was developed to handle influenza, and its wonderful benefits and characteristic factors made scientists develop the drug further into something useful. This is how the antiviral drug for treating COVID-19 was invented.
Method of Treatment
Patients suffering from SARS, and COVID-19 positive confirmations were chosen for the clinical trials. All these patients are the ones that have the onset of the disorder within 7 days of infection.
The patients were subjected to the treatment with Molnupiravir randomly. Some were injected with a 1:1 to 200mg drug supplement, and some were subjected to 3:1 to 400mg to 800mg drug supplement at a time, and twice a day. The treatment followed for the 5 days continuously with the same level of medications along with the constant supervision on their condition.
The activity of Molnupiravir antiviral medication was assessed as the actual time duration, which was required to make the viral RNA undetectable due to the action of the medications. This was done by the process known as a reverse transcriptase-polymerase chain reaction, and the infectious virus was eliminated or even isolated with the help of nasopharyngeal swabs.
Status of approval for the drug
The FDA has approved the usage of Molnupiravir for treating COVID-19 and all the secondary symptoms that are associated with this drug. Hence, it has been dispatched to all the under-developed countries to treat the infected patients in these places. The next was the middle-developed countries that received the delivery of this drug for treating their COVID-19 patients.
Studies have shown that the effects of Molnupiravir will be nullified after certain time duration, and hence the further batches of this drug should be of the strong quality so that their effects stay in the bloodstreams for decades. The research is still going on to find out the best way of making the tablets from this drug, instead of sticking to just the oral and injection forms.
Molnupiravir is like a light for the COVID-19 patients when there is no hope to cure the severity of their condition. Hence, many countries are demanding the supply of this drug from SMPharmacueticals in bulk quantities.